Delayed intubation is associated with mortality in patients with severe COVID-19: A single-centre observational study in Switzerland.
Acute respiratory distress syndrome
COVID-19
delayed intubation
intensive care unit
mortality
timing intubation
Journal
Anaesthesia, critical care & pain medicine
ISSN: 2352-5568
Titre abrégé: Anaesth Crit Care Pain Med
Pays: France
ID NLM: 101652401
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
12
01
2022
revised:
28
03
2022
accepted:
28
03
2022
pubmed:
30
4
2022
medline:
2
8
2022
entrez:
29
4
2022
Statut:
ppublish
Résumé
Switzerland experienced two waves of COVID-19 in 2020, but with a different ICU admission and treatment management strategy. The timing of ICU admission and intubation remains a matter of debate in severe patients. The aim of our study was to describe the characteristics of ICU patients between two subsequent waves of COVID-19 who underwent a different management strategy and to assess whether the timing of intubation was associated with differences in mortality. We conducted a prospective observational study of all adult patients with acute respiratory failure due to COVID-19 who required intubation between the 9 Two hundred twenty-three patients were intubated during the study period; 124 during the first wave, and 99 during the second wave. Patients admitted to the ICU during the second wave had a higher SAPS II severity score (52.5 vs. 60; p = 0.01). The time from hospital admission to intubation was significantly longer during the second compared to the first wave (4 days [IQR, 1-7] vs. 2 days [IQR, 0-4]; p < 0.01). All-cause ICU mortality was significantly higher during the second wave (42% vs. 23%; p < 0.01). In a multivariate analysis, the delay between hospital admission and intubation was significantly associated with ICU mortality (OR 3.25 [95% CI, 1.38-7.67]; p < 0.05). In this observational study, delayed intubation was associated with increased mortality in patients with severe COVID-19. Further randomised controlled trials are needed.
Identifiants
pubmed: 35487412
pii: S2352-5568(22)00073-X
doi: 10.1016/j.accpm.2022.101092
pmc: PMC9040513
pii:
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
101092Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.